Acura Pharmaceuticals Financials
| ACURDelisted Stock | USD 0.05 0.00 0.00% |
With this module, you can analyze Acura financials for your investing period. You should be able to track the changes in Acura Pharmaceuticals individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Acura |
Understanding current and past Acura Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Acura Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Acura Pharmaceuticals' assets may result in an increase in income on the income statement.
The data published in Acura Pharmaceuticals' official financial statements usually reflect Acura Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Acura Pharmaceuticals. For example, before you start analyzing numbers published by Acura accountants, it's critical to develop an understanding of what Acura Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Acura Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Acura Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Acura Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Acura Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Acura Pharmaceuticals' management manipulating its earnings.
Acura Pharmaceuticals Stock Summary
Acura Pharmaceuticals competes with Alimera Sciences, and ARCA Biopharma. Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 12 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US00509L8028 |
| CUSIP | 00509L703 00509L802 406369108 |
| Location | Illinois; U.S.A |
| Business Address | 616 N North |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.acurapharm.com |
| Phone | 847 705 7709 |
| Currency | USD - US Dollar |
You should never invest in Acura Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Acura OTC Stock, because this is throwing your money away. Analyzing the key information contained in Acura Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Acura Pharmaceuticals Key Financial Ratios
Generally speaking, Acura Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Acura Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Acura Pharmaceuticals over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Acura Pharmaceuticals reports annually and quarterly.Acura Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Acura Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Acura Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Acura Pharmaceuticals competition to find correlations between indicators driving Acura Pharmaceuticals's intrinsic value. More Info.Acura Pharmaceuticals is rated third in return on asset category among related companies. It is rated third in profit margin category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Acura Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Acura Pharmaceuticals' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Acura Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Acura Pharmaceuticals Market Pulse
| Quote | 0.05 |
| Change(%) | 0.00 |
| Change | 0.00 |
| Open | 0.05 |
| Low | 0.05 |
| High | 0.05 |
| Volume | 0 |
| Exchange | OTCQB |
About Acura Pharmaceuticals Financials
What exactly are Acura Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Acura Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential Acura Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Acura Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Acura Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Acura Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Acura Pharmaceuticals Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Acura Pharmaceuticals is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Acura has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Acura Pharmaceuticals' financials are consistent with your investment objective using the following steps:- Review Acura Pharmaceuticals' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Acura Pharmaceuticals' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Acura Pharmaceuticals' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Acura Pharmaceuticals' stock is overvalued or undervalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Acura OTC Stock
If you are still planning to invest in Acura Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acura Pharmaceuticals' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |